The present invention relates to compounds with formula (I) or a pharmaceutically acceptable salt thereof:
wherein;
T is a (4 to 10)-membered heterocyclyl and wherein R
1
, R
2
and R
3
are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of the 11-β-hsd-1 enzyme.